Skip to main content

Table 1 General characteristics at enrolment as a function of weight status

From: Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali

 

Underweight

n (%)

Normal weight

n (%)

Overweight

n (%)

p-value

AS + AQ arm (n = 250)

19 (7.6)

137 (54.8)

94 (37.6)

0.11

AS + SP arm (n = 248)

29 (11.69)

138 (55.65)

81 (32.66)

AS arm (n = 251)

30 (11.95)

152 (60.56)

69 (27.49)

Male (n = 354)

36 (10.17)

201 (56.78)

117 (33.05)

0.95

Female (n = 395)

42 (10.63)

226 (57.22)

127 (32.15)

< 5 (n = 513)

49 (9.55)

259 (50.49)

205 (39.96)

< 0.0001

≥ 5 (n = 236)

29 (12.29)

168 (71.19)

39 (16.53)

Temperature (°C) median (interquartile range)

38.50 (37.80, 39.18)

38.40 (37.80, 38.90)

38.65 (38.00, 39.10)

 

P. falciparum (/µl) median (interquartile range)

17,800 (5925, 33,060)

14,850 (7162, 28,160)

17,660 (9638, 36,380)

Haemoglobin (g/dl) median (interquartile range)

9.85 (8.48, 11.40)

10.59 (9.50, 11.80)

9.50 (8.48, 10.90)

ASAT (UI/l) median (interquartile range)

32.20 (23.30, 46.70)

36.00 (27.70, 43.90)

38.20 (29.40, 48.30)

ALAT (UI/l) median (interquartile range)

15.15 (11.08, 20.10)

17.00 (12.50, 23.87)

23.31 (12.00, 24.00)

Creatinine (mg/dl) median (interquartile range)

0.52 (0.46, 0.75)

0.55 (0.48, 0.68)

0.53 (0.44, 0.66)

Artesunate (mean ± SD in mg/kg)

58.22 ± 32.29

69.40 ± 29.39

61.57 ± 22.77

Amodiaquine (mean ± SD in mg/kg)

165.08 ± 69.89

185.3 ± 89.99

155.82 ± 48.07

Sulfadoxine (mean ± SD in mg/kg)

354.17 ± 185.93

444.85 ± 194.70

387.66 ± 199.75

  1. N: frequency; AS + AQ: artesunate plus amodiaquine; AS + SP: artesunate + sulfadoxine–pyrimethamine; AS: artesunate; Q1: 25th percentile; Q3: 75th percentile